We created a few short clips with helpful tips. For easy access, we have included links to the Getting Started Guide and other helpful resources. If you should still have questions, after accessing these resources, please contact us at 1-800-646-4633 option 1.
Click on the videos below to learn more about continuous glucose monitoring (CGM) and the Guardian™ Connect system.
Click on the videos below to learn how to download and install the Guardian™ Connect app. Additionally, you can learn more about the Guardian™ Sensor 3 and programming your own glucose alerts.
Click on the videos below to learn how to calibrate your Guardian™ Connect system and learn more on the CGM system alerts and caring for your transmitter.
Click on the videos on the right to learn about what a care partner account is and how you may set up your own care partner(s) accounts.
* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance and provides access to additional algorithms and insights that can inform users of clinically relevant glucose patterns
† At the time of FDA approval of the Guardian Connect System
§ Projected alerts available only with user invention of system scan per Freestyle Libre IFU.
1 Dexcom IFU
2 Guardian Connect IFU
3 With threshold and predictive alerts within the 15 minute period before or after your blood sugar goes below 70 mg/dL.
4 Per system description, a dedicated monitor must be purchased
5 Corriveau EA, Durso PJ, Kaufman ED,et al. Effect of CareLink, aninternet-based insulin pump monitoring system, on glycemiccontrol in rural and urban children with type1 diabetes mellitus. PediatricDiabetes. 2008;9(PartII):360–366.
6 The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing firstname.lastname@example.org or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219
Important Safety Information: Guardian™ Connect CGM System
The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and http://www.medtronicdiabetes.com/importantsafetyinformation.
For proper instructions on inserting the Guardian™ sensor 3, visit the support webpage for inserting your sensor.
With Watson is a trademark of International Business Machines Corporation, registered in many jurisdictions worldwide.
© Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic™. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.